• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Why Clovis Oncology Shares Got a Bump This Week

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 28, 2021 at 09:12: PM
via
  • Clovis may be benefitting from a short-squeeze effort by retail investors.
  • The jump was surprising considering the company’s disappointing second-quarter numbers.
  • The company has one marketed drug, Rubraca.

article source
 




Top Bottom
Back
Quote